
Sign up to save your podcasts
Or


If the past year has shown us anything, it’s that GLP-1s are here to stay. But as time passes, we’re also learning more about them — from new uses to new side effects to unexpected cultural trends. So have these drugs really lived up to the promise of easy weight loss?
On this episode of Health Matters, Mayo Clinic dietitian Tara Schmidt rejoins us — one year after our original GLP-1 episode — to talk about what we’ve learned so far, what’s surprised researchers and patients, and what questions still need answers.
By Mayo Clinic Press4.9
2828 ratings
If the past year has shown us anything, it’s that GLP-1s are here to stay. But as time passes, we’re also learning more about them — from new uses to new side effects to unexpected cultural trends. So have these drugs really lived up to the promise of easy weight loss?
On this episode of Health Matters, Mayo Clinic dietitian Tara Schmidt rejoins us — one year after our original GLP-1 episode — to talk about what we’ve learned so far, what’s surprised researchers and patients, and what questions still need answers.

27,011 Listeners

7,890 Listeners

6,467 Listeners

298 Listeners

113,121 Listeners

56,944 Listeners

8,043 Listeners

29,272 Listeners

2,131 Listeners

5,553 Listeners

20,222 Listeners

13,710 Listeners

49 Listeners

41 Listeners

12,559 Listeners